BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1212@pharmaconomics
DTSTAMP:20260707T033943Z
DTSTART;VALUE=DATE:20260501
DTEND;VALUE=DATE:20260502
SUMMARY:AZN AdCom — Truqap
DESCRIPTION:An FDA advisory committee reviews Truqap for PTEN-deficient metastatic hormone-sensitive prostate cancer around May 1\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/901832/000165495426004226/a7026c.htm\n\nTrack it: https://pharmaconomics.com/e/1212
URL:https://pharmaconomics.com/e/1212
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:AZN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR